Browse by author
Lookup NU author(s): Professor Tim Goodship
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2016 International Society of Nephrology In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference where key issues in the management of these 2 diseases were considered by a global panel of experts. Areas addressed included renal pathology, clinical phenotype and assessment, genetic drivers of disease, acquired drivers of disease, and treatment strategies. In order to help guide clinicians who are caring for such patients, recommendations for best treatment strategies were discussed at length, providing the evidence base underpinning current treatment options. Knowledge gaps were identified and a prioritized research agenda was proposed to resolve outstanding controversial issues.
Author(s): Goodship THJ, Cook HT, Fakhouri F, Fervenza FC, Fremeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodriguez de Cordoba S, Roumenina LT, Sethi S, Smith RJH, Alpers CE, Appel GB, Ardissino G, Ariceta G, Arici M, Bagga A, Bajema IM, Blasco M, Burke L, Cairns TD, Carratala M, D'Agati VD, Daha MR, De Vriese AS, Dragon-Durey M-A, Fogo AB, Galbusera M, Gale DP, Haller H, Johnson S, Jozsi M, Karpman D, Lanning L, Le Quintrec M, Licht C, Loirat C, Monfort F, Morgan BP, Noel L-H, O'Shaughnessy MM, Rabant M, Rondeau E, Ruggenenti P, Sheerin NS, Smith J, Spoleti F, Thurman JM, van de Kar NCAJ, Vivarelli M, Zipfel PF
Publication type: Conference Proceedings (inc. Abstract)
Publication status: Published
Conference Name: Kidney International
Year of Conference: 2017
Pages: 539-551
Publisher: Elsevier B.V.
DOI: 10.1016/j.kint.2016.10.005
